Acelyrin

Acelyrin, Inc

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Acelyrin, Inc. is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology.

02Backed By4 investors

vPvenBio Partners→WBWestlake BioPartners→SB

Is this your company? Claim your profile

Samsara BioCapital

→

DCDecheng Capital→

03Recent Activity

FROM Westlake BioPartners

Portfolio company ACELYRIN merged with Alumis Inc. to form a late-stage clinical immunology biopharma company.

EXIT·investors.alumis.com

MAY 2025

04Similar Companies

TB

Tourmaline Bio

Biotech & Life Sciences

→

CP

Calluna Pharma

Biotech & Life Sciences

→

ST

Sitryx Therapeutics

Biotech & Life Sciences

→

IT

iTeos Therapeutics

Biotech & Life Sciences

→

RT

RAPT Therapeutics

Biotech & Life Sciences

→

05Startup DNA

8

signals

Sectors
Business Model
Technology